BioMarin Insider Buying Signals Strong Confidence in Enzyme Therapy Pipeline
BioMarin insider buying signals strong confidence in its enzyme‑therapy pipeline, positioning the Nasdaq biotech stock for long‑term upside.
4 minutes to read
BioMarin Pharmaceutical Inc
BioMarin CFO Buys Shares, Boosting Investor Confidence & Growth Outlook
BioMarin CFO’s insider buying signals confidence, aligning with recent Amicus acquisition and debt‑funded growth—an insider‑driven boost for investors.
3 minutes to read